These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1627053)

  • 1. Methodological issues in the assessment of human immunodeficiency virus-related cognitive impairment.
    Miller EN; Satz P; Bing EG; van Gorp W; Morganstern H; Visscher B
    Arch Gen Psychiatry; 1992 Jul; 49(7):586-8. PubMed ID: 1627053
    [No Abstract]   [Full Text] [Related]  

  • 2. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals.
    Moore LH; van Gorp WG; Hinkin CH; Stern MJ; Swales T; Satz P
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):37-44. PubMed ID: 9017527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between age and cognitive function in HIV-infected men.
    Kissel EC; Pukay-Martin ND; Bornstein RA
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):180-4. PubMed ID: 15939971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodological problems in the evaluation of cognitive disorders associated with HIV].
    Pereda M; Gómez del Barrio A; Ayuso Mateos JL
    Neurologia; 1999 Nov; 14(9):452-8. PubMed ID: 10613019
    [No Abstract]   [Full Text] [Related]  

  • 5. Objective memory as an indicator of functional impairment in native Spanish-speaking patients with HIV infection.
    Torres AG; González-Andrade A; Fernández Muñoz JJ; García MP; Vergara-Moragues E
    AIDS Care; 2019 Dec; 31(12):1540-1547. PubMed ID: 30957528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of HIV-related neuropsychological impairment: a review of methodological aspects].
    RodríIguez Alvarez M; Rodriguez Salgado D
    Actas Esp Psiquiatr; 2003; 31(2):79-84. PubMed ID: 12677472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical validation of the NeuroScreen.
    Ellis RJ; Evans SR; Clifford DB; Moo LR; McArthur JC; Collier AC; Benson C; Bosch R; Simpson D; Yiannoutsos CT; Yang Y; Robertson K; ;
    J Neurovirol; 2005 Dec; 11(6):503-11. PubMed ID: 16338744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive reserve during neuropsychological performance in HIV intravenous drug users.
    Vázquez-Justo E; Blanco AP; Vergara-Moragues E; Gestoso CG; Pérez-García M
    Appl Neuropsychol Adult; 2014; 21(4):288-96. PubMed ID: 25265310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychological impairment in human immunodeficiency virus-positive children].
    Millana-Cuevas LC; Portellano JA; Martinez-Arias R
    Rev Neurol; 2007 Mar 16-31; 44(6):366-74. PubMed ID: 17385174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological evaluation of neurologically asymptomatic HIV-infected children.
    Bisiacchi PS; Suppiej A; Laverda A
    Brain Cogn; 2000; 43(1-3):49-52. PubMed ID: 10857661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological deficit in haemophiliacs with human immunodeficiency virus.
    Turnbull O; Saling MM; Kaplan-Solms K; Cohn R; Schoub B
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):175-7. PubMed ID: 2019847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between employment and neuropsychological impairment in HIV infection.
    van Gorp WG; Baerwald JP; Ferrando SJ; McElhiney MC; Rabkin JG
    J Int Neuropsychol Soc; 1999 Sep; 5(6):534-9. PubMed ID: 10561934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus.
    Mapou RL; Law WA; Martin A; Kampen D; Salazar AM; Rundell JR
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):86-93. PubMed ID: 8428141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cognitive impairment in human immunodeficiency virus.
    Valcour V; Paul R; Chiao S; Wendelken LA; Miller B
    Clin Infect Dis; 2011 Oct; 53(8):836-42. PubMed ID: 21921226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders.
    Robertson K; Yosief S
    Semin Neurol; 2014 Feb; 34(1):21-6. PubMed ID: 24715485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus.
    Martin EM; Novak RM; Fendrich M; Vassileva J; Gonzalez R; Grbesic S; Nunnally G; Sworowski L
    J Int Neuropsychol Soc; 2004 Mar; 10(2):298-300. PubMed ID: 15012850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.